Management of Chronic Respiratory Diseases: A Retrospective Analysis of Demographic Predictors and Treatment Outcomes in Asthma and Chronic Obstructive Pulmonary Disease
Context: Chronic respiratory conditions such as asthma and COPD represent significant global health challenges. This study aims to elucidate the interplay between demographic characteristics, disease prevalence, and treatment outcomes by examining a cohort of 203 patients with these disorders. Aims:...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Journal of Nature and Science of Medicine |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jnsm.jnsm_164_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Context:
Chronic respiratory conditions such as asthma and COPD represent significant global health challenges. This study aims to elucidate the interplay between demographic characteristics, disease prevalence, and treatment outcomes by examining a cohort of 203 patients with these disorders.
Aims:
The study analyses demographic profiles, disease prevalence, and treatment outcomes among individuals with asthma and COPD. It also investigates relationships among exacerbation rates, comorbidities, and healthcare utilization.
Subjects and Methods:
A retrospective analysis focused on patient demographics, smoking habits, comorbidities, medication use, exacerbation frequency, and healthcare utilization. Statistical Analysis Used: Prevalence, outcomes, and management trends were assessed using Microsoft Excel and SPSS (v22). Descriptive statistics (mean, SD, frequency) were calculated. Chi-square tests were used for categorical variables; t-tests for continuous variables. P <0.05 was considered statistically significant.
Results:
The cohort mainly comprised older adults, with 60.1% female and 37.4% aged 61–80. Most (92.6%) were Saudi nationals. Only 12.8% were current smokers; 76.4% had unclear smoking histories. Asthma was more prevalent (63.1%) than COPD (29.1%); 7.9% had both. Most patients used inhaled corticosteroids (99%) and long-acting β-agonists (95.1%). ICU admissions occurred in 38.4%, with 45.8% experiencing exacerbations. Pneumonia was undiagnosed in 56.7%. Among COVID-19 patients, 5.4% had exacerbations. The overall mortality rate was 7.9%.
Conclusions:
Statistically significant associations between disease type, age, healthcare utilization, and ICU admissions highlight the need for stratified management. Incorporating validated predictors may improve prognosis and reduce mortality. |
|---|---|
| ISSN: | 2589-627X 2589-6288 |